Cover Picture: 2-Anilinobenzamides as SIRT Inhibitors (ChemMedChem 10/2006)
✍ Scribed by Takayoshi Suzuki; Keiko Imai; Hidehiko Nakagawa; Naoki Miyata
- Book ID
- 102100627
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 35 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
✦ Synopsis
The cover picture shows the model of a SIRT inhibitor, 2‐anilinobenzamide, bound to the catalytic core of a SIRT homologue. SIRTs catalyze the deacetylation of several proteins such as histones, p53, and γ‐tubulin, and are involved in certain disease states including cancer. SIRT inhibitors can be considered as potential therapeutic agents. This simple compound, which was discovered from a nicotinamide‐ and benzamide‐focused chemical library, shows potent SIRT1 inhibition competitive with the acetylated lysine substrate and causes p53 acetylation in human colon cancer HCT116 cells. For more details, see the Communication by T. Suzuki, N. Miyata et al. on p. 1059 ff.
📜 SIMILAR VOLUMES
The cover picture shows the hypothetical binding motif of a novel potent protein kinase CK2 inhibitor, 4-bromo-3,8-dihydroxy-benzo[c]chromen-6-one, which shows a K i value of 7 nm. CK2 is a ubiquitous, essential, and highly pleiotropic protein kinase, and abnormally high constitutive activity of thi